Search results
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June...
Benzinga· 5 days agoMid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX,...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 4 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 3 days agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CBS 58 Milwaukee· 6 days agoThe FDA told the advisory committee Wednesday that studies have shown that the currently available Covid-19 vaccines appear to be less effective against the variants that ...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 7 days agoThe submission is based on FDA guidance, which advised that COVID-19 vaccines should be updated to a...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
WKBT La Crosse· 6 days agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency tell vaccine manufacturers to update the Covid-19 shots ...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Reuters via AOL· 7 days agoThe Food and Drug Administration's advisory is in line with European and World Health Organization...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 2 days agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Moderna's Combo Flu/Covid Shot Topped Rivals From Sanofi, GSK
Investor's Business Daily· 4 days agoIn a study of about 8,000 people, Moderna's combination vaccine proved it's not inferior to the...